Skip to content

Palo Alto Investors LP

Follow

13F filer, CIK 1306923, PALO ALTO, CA

Palo Alto Investors LP reported $672,150,352 across 56 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 59.91% of the portfolio.

Accepted , ingested 13F-HR 0002073679-26-000180

Period
2026-09-30
Reported value
$672M
Holdings
56
Top 10 weight
59.91%
New
4
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TRAXadded+137,608$4.88M
DYNadded+234,406$3.78M
INSMadded+29,665$3.39M
MIRMadded+38,506$3.29M
TARAnew+1,035,964$3.16M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IOVAreduced-1,824,753-$27M
ACADreduced-378,488-$7.63M
CDNAreduced-107,269-$6.97M
SNDXreduced-268,630-$5.05M
PTCTreduced-43,497-$2.82M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002073679-26-000180, largest first. % of portfolio is the value over $672,150,352, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 386,413 shares; 2025Q1: 404,196 shares; 2025Q2: 406,469 shares; 2025Q3: 862,613 shares; 2025Q4: 903,916 shares; 2026Q1: 921,607 shares; 2026Q2: 918,846 shares; 2026Q3: 875,349 shares 875,349$56.7M8.44%-43,497Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,041,685 shares; 2025Q1: 3,211,314 shares; 2025Q2: 3,429,329 shares; 2025Q3: 7,618,132 shares; 2025Q4: 7,116,676 shares; 2026Q1: 6,349,563 shares; 2026Q2: 5,296,209 shares; 2026Q3: 3,471,456 shares 3,471,456$51.4M7.65%-1,824,753Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,603,465 shares; 2025Q1: 987,153 shares; 2025Q2: 865,113 shares; 2025Q3: 491,805 shares; 2025Q4: 489,482 shares; 2026Q1: 415,269 shares; 2026Q2: 413,980 shares; 2026Q3: 443,645 shares 443,645$50.6M7.53%+29,665Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,748,599 shares; 2025Q1: 2,663,925 shares; 2025Q2: 2,563,209 shares; 2025Q3: 2,466,684 shares; 2025Q4: 2,484,031 shares; 2026Q1: 2,872,695 shares; 2026Q2: 2,864,096 shares; 2026Q3: 2,485,608 shares 2,485,608$50.1M7.45%-378,488Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,067,266 shares; 2025Q1: 991,207 shares; 2025Q2: 840,470 shares; 2025Q3: 754,007 shares; 2025Q4: 746,256 shares; 2026Q1: 685,182 shares; 2026Q2: 682,777 shares; 2026Q3: 642,455 shares 642,455$38.5M5.73%-40,322Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 64,700 shares; 2025Q1: 64,700 shares; 2025Q2: 64,700 shares; 2025Q3: 64,700 shares; 2025Q4: 156,421 shares; 2026Q1: 325,175 shares; 2026Q2: 348,808 shares; 2026Q3: 387,314 shares 387,314$33.1M4.93%+38,506Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 155,714 shares; 2025Q1: 105,228 shares; 2025Q2: 95,482 shares; 2025Q3: 58,186 shares; 2025Q4: 58,186 shares; 2026Q1: 62,809 shares; 2026Q2: 62,587 shares; 2026Q3: 58,875 shares 58,875$31.9M4.75%-3,712Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 333,391 shares; 2025Q2: 264,976 shares; 2025Q3: 1,262,674 shares; 2025Q4: 1,472,197 shares; 2026Q1: 1,652,972 shares; 2026Q2: 1,647,521 shares; 2026Q3: 1,881,927 shares 1,881,927$30.3M4.51%+234,406Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 190,148 shares; 2025Q1: 204,923 shares; 2025Q2: 205,759 shares; 2025Q3: 185,661 shares; 2025Q4: 183,571 shares; 2026Q1: 140,719 shares; 2026Q2: 140,279 shares; 2026Q3: 132,918 shares 132,918$30M4.47%-7,361Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 843,971 shares; 2025Q1: 1,020,713 shares; 2025Q2: 812,821 shares; 2025Q3: 673,520 shares; 2025Q4: 690,032 shares; 2026Q1: 638,161 shares; 2026Q2: 603,489 shares; 2026Q3: 595,264 shares 595,264$29.9M4.45%-8,225Timeline
CDNACAREDX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 316,204 shares; 2025Q4: 478,220 shares; 2026Q1: 531,870 shares; 2026Q2: 531,870 shares; 2026Q3: 424,601 shares 424,601$27.6M4.11%-107,269Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 603,489 shares; 2026Q3: 741,097 shares 741,097$26.3M3.91%+137,608Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 145,691 shares; 2025Q3: 224,300 shares; 2025Q4: 317,456 shares; 2026Q1: 401,719 shares; 2026Q2: 416,646 shares; 2026Q3: 396,529 shares 396,529$26M3.86%-20,117Timeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 814,191 shares; 2025Q1: 1,002,061 shares; 2025Q2: 962,396 shares; 2025Q3: 1,256,159 shares; 2025Q4: 1,298,964 shares; 2026Q1: 1,280,439 shares; 2026Q2: 1,280,439 shares; 2026Q3: 1,209,774 shares 1,209,774$19.3M2.87%-70,665Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 298,575 shares; 2026Q1: 550,408 shares; 2026Q2: 550,408 shares; 2026Q3: 689,344 shares 689,344$12.8M1.91%+138,936Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,384,192 shares; 2026Q1: 2,948,090 shares; 2026Q2: 2,948,090 shares; 2026Q3: 2,811,222 shares 2,811,222$11.9M1.77%-136,868Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 405,193 shares; 2025Q1: 444,367 shares; 2025Q2: 444,367 shares; 2025Q3: 654,930 shares; 2025Q4: 794,507 shares; 2026Q1: 864,986 shares; 2026Q2: 864,986 shares; 2026Q3: 596,356 shares 596,356$11.2M1.67%-268,630Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 296,408 shares; 2026Q2: 399,856 shares; 2026Q3: 343,101 shares 343,101$11.1M1.65%-56,755Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 48,750 shares; 2025Q3: 369,531 shares; 2025Q4: 461,294 shares; 2026Q1: 596,495 shares; 2026Q2: 596,495 shares; 2026Q3: 710,029 shares 710,029$10.7M1.59%+113,534Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,737,964 shares; 2025Q1: 1,659,734 shares; 2025Q2: 1,274,753 shares; 2025Q3: 1,324,028 shares; 2025Q4: 1,320,510 shares; 2026Q1: 1,208,568 shares; 2026Q2: 1,143,155 shares; 2026Q3: 1,129,363 shares 1,129,363$9.46M1.41%-13,792Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 110,719 shares; 2025Q1: 110,719 shares; 2025Q2: 110,719 shares; 2025Q3: 110,719 shares; 2025Q4: 110,719 shares; 2026Q1: 230,453 shares; 2026Q2: 167,525 shares; 2026Q3: 158,946 shares 158,946$9.36M1.39%-8,579Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 289,308 shares; 2025Q1: 221,513 shares; 2025Q2: 221,021 shares; 2025Q3: 183,938 shares; 2025Q4: 242,560 shares; 2026Q1: 242,560 shares; 2026Q2: 242,560 shares; 2026Q3: 203,680 shares 203,680$8.25M1.23%-38,880Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,532,419 shares; 2026Q1: 1,514,504 shares; 2026Q2: 5,831,813 shares; 2026Q3: 7,148,673 shares 7,148,673$7.43M1.11%+1,316,860Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 276,578 shares; 2025Q2: 268,783 shares; 2025Q3: 265,497 shares; 2025Q4: 212,499 shares; 2026Q1: 213,601 shares; 2026Q2: 213,601 shares; 2026Q3: 200,984 shares 200,984$6.68M0.99%-12,617Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 811,268 shares; 2025Q1: 1,419,468 shares; 2025Q2: 1,246,033 shares; 2025Q3: 1,246,033 shares; 2025Q4: 1,183,195 shares; 2026Q1: 1,391,382 shares; 2026Q2: 1,391,382 shares; 2026Q3: 1,337,217 shares 1,337,217$6.51M0.97%-54,165Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 569,832 shares; 2025Q1: 776,028 shares; 2025Q2: 1,390,028 shares; 2025Q3: 1,566,840 shares; 2025Q4: 1,566,840 shares; 2026Q1: 1,613,430 shares; 2026Q2: 1,613,430 shares; 2026Q3: 1,156,396 shares 1,156,396$6.08M0.9%-457,034Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 226,304 shares; 2026Q1: 229,763 shares; 2026Q2: 229,763 shares; 2026Q3: 548,071 shares 548,071$5.19M0.77%+318,308Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 37,772 shares; 2025Q1: 37,772 shares; 2025Q2: 37,772 shares; 2025Q3: 45,735 shares; 2025Q4: 41,520 shares; 2026Q1: 41,520 shares; 2026Q2: 31,389 shares; 2026Q3: 31,389 shares 31,389$4.56M0.68%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 44,359 shares; 2026Q3: 162,874 shares 162,874$3.96M0.59%+118,515Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,035,964 shares 1,035,964$3.16M0.47%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 220,226 shares 220,226$2.96M0.44%newTimeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 39,473 shares; 2025Q1: 39,473 shares; 2025Q2: 39,473 shares; 2025Q3: 33,640 shares; 2025Q4: 33,640 shares; 2026Q1: 33,640 shares; 2026Q2: 33,640 shares; 2026Q3: 33,640 shares 33,640$2.9M0.43%0Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 246,093 shares; 2026Q2: 309,685 shares; 2026Q3: 325,480 shares 325,480$2.62M0.39%+15,795Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 13,334 shares; 2025Q2: 13,334 shares; 2025Q3: 18,117 shares; 2025Q4: 18,117 shares; 2026Q1: 18,117 shares; 2026Q2: 18,117 shares; 2026Q3: 18,117 shares 18,117$2.57M0.38%0Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$2.47M0.37%0Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 149,490 shares 149,490$2.39M0.36%newTimeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 125,861 shares; 2025Q1: 125,861 shares; 2025Q2: 125,861 shares; 2025Q3: 105,427 shares; 2025Q4: 72,022 shares; 2026Q1: 84,631 shares; 2026Q2: 84,631 shares; 2026Q3: 84,631 shares 84,631$2.2M0.33%0Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,985 shares; 2025Q4: 59,985 shares; 2026Q1: 59,985 shares; 2026Q2: 33,546 shares; 2026Q3: 25,563 shares 25,563$2.13M0.32%-7,983Timeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 44,625 shares; 2025Q3: 41,226 shares; 2025Q4: 41,226 shares; 2026Q1: 39,605 shares; 2026Q2: 39,605 shares; 2026Q3: 36,949 shares 36,949$2.04M0.3%-2,656Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,037,421 shares; 2025Q1: 1,037,421 shares; 2025Q2: 1,037,421 shares; 2025Q3: 1,037,421 shares; 2025Q4: 1,037,421 shares; 2026Q1: 1,010,510 shares; 2026Q2: 864,277 shares; 2026Q3: 864,277 shares 864,277$2.01M0.3%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 32,195 shares; 2026Q2: 32,195 shares; 2026Q3: 30,036 shares 30,036$1.98M0.29%-2,159Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,206 shares; 2025Q1: 25,206 shares; 2025Q2: 25,206 shares; 2025Q3: 19,614 shares; 2025Q4: 19,614 shares; 2026Q1: 19,614 shares; 2026Q2: 19,614 shares; 2026Q3: 19,614 shares 19,614$1.93M0.29%0Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 772,652 shares; 2025Q1: 772,652 shares; 2025Q2: 772,652 shares; 2025Q3: 1,020,547 shares; 2025Q4: 538,079 shares; 2026Q1: 508,846 shares; 2026Q2: 326,609 shares; 2026Q3: 326,609 shares 326,609$1.83M0.27%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 96,519 shares; 2026Q1: 51,345 shares; 2026Q2: 51,345 shares; 2026Q3: 47,902 shares 47,902$1.78M0.27%-3,443Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,985 shares; 2025Q1: 3,985 shares; 2025Q2: 3,985 shares; 2025Q3: 3,985 shares; 2025Q4: 3,985 shares; 2026Q1: 3,985 shares; 2026Q2: 3,985 shares; 2026Q3: 3,985 shares 3,985$1.52M0.23%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 115,616 shares; 2026Q1: 115,616 shares; 2026Q2: 115,616 shares; 2026Q3: 115,616 shares 115,616$1.44M0.21%0Timeline
EHTHEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,878,127 shares; 2025Q1: 1,684,336 shares; 2025Q2: 1,577,850 shares; 2025Q3: 1,544,619 shares; 2025Q4: 1,531,429 shares; 2026Q1: 1,482,797 shares; 2026Q2: 1,482,797 shares; 2026Q3: 1,431,535 shares 1,431,535$1.02M0.15%-51,262Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 104,410 shares; 2026Q2: 104,410 shares; 2026Q3: 104,410 shares 104,410$998K0.15%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 24,500 shares; 2025Q1: 24,500 shares; 2025Q2: 24,500 shares; 2025Q3: 24,500 shares; 2025Q4: 24,500 shares; 2026Q1: 24,500 shares; 2026Q2: 24,500 shares; 2026Q3: 24,500 shares 24,500$995K0.15%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,787 shares; 2026Q2: 1,787 shares; 2026Q3: 1,787 shares 1,787$901K0.13%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 72,634 shares 72,634$893K0.13%newTimeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 248,934 shares; 2025Q1: 248,934 shares; 2025Q2: 248,934 shares; 2025Q3: 221,071 shares; 2025Q4: 221,071 shares; 2026Q1: 201,890 shares; 2026Q2: 201,890 shares; 2026Q3: 188,351 shares 188,351$693K0.1%-13,539Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,772 shares; 2026Q1: 8,772 shares; 2026Q2: 8,772 shares; 2026Q3: 8,772 shares 8,772$608K0.09%0Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 108,865 shares; 2025Q1: 108,865 shares; 2025Q2: 108,865 shares; 2025Q3: 108,865 shares; 2025Q4: 108,865 shares; 2026Q1: 108,865 shares; 2026Q2: 108,865 shares; 2026Q3: 108,865 shares 108,865$572K0.09%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 188,807 shares; 2025Q4: 188,807 shares; 2026Q1: 188,807 shares; 2026Q2: 188,807 shares; 2026Q3: 188,807 shares 188,807$313K0.05%0Timeline
ALDXALDEYRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 225,465 shares; 2025Q1: 225,465 shares; 2025Q2: 225,465 shares; 2025Q3: 225,465 shares; 2025Q4: 225,465 shares; 2026Q1: 155,709 shares; 2026Q2: 155,709 shares; 2026Q3: 155,709 shares 155,709$192K0.03%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002073679-26-000180 base2026-11-16